Improving Return on Investment in Pharmaceutical MarketingDecision ResourcesJune 17, 2008 28 Pages - SKU: DECR1812803 |
| Pharmaceutical marketing is in trouble-campaigns are not as effective as they should be, and costs
have spiraled out of control. Marketing expenditures are the single largest corporate investment at most
pharmaceutical companies and are running at almost twice the spend of R&D. How can companies improve
their return on investment (ROI)? We propose a three-tiered approach to improve the value of pharmaceutical
marketing investments by increasing ROI. Get the Answers You Need to Shape Your Strategy
|
Related Markets
General Pharmaceuticals Reports
- Perspective: TAKE Solutions Gives Leading Pharma an Edge in Drug Serialization
- Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
- The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
- Patient Adherence and Compliance: Improving Outcomes through Patient Engagement Programs
- The Next Generation of Pharmaceutical Marketing Strategies – Understanding All of the Strategic Considerations Needed in the Age of Multiple Stakeholders

